Y Ohata, Y Tomita, M Nakayama… - Drug metabolism and …, 2011 - ncbi.nlm.nih.gov A population pharmacokinetic (PK) model for meropenem in Japanese pediatric patients with various infectious diseases has been developed based on 116 plasma concentrations from 50 pediatric patients. The population PK parameters developed in this analysis are useful for ... Cited by 1
R Shi… - Dermatokinetics of Therapeutic Agents, 2011 - books.google.com ... Pharmacokinetics can be used in drug development to optimize therapy; it is used to determine the dose, dosageregimen (the frequency of dosing), and dosage formula- tions. Choosing the wrong dose, dosageregimen, or dosage form will render any drug ineffective. ... Related articles
M Irikura, A Fujiyama, F Saita… - Pediatrics …, 2011 - Wiley Online Library ... Title: Evaluation of the Vancomycin DosageRegimen Based on Serum Creatinine Used in Neonatal Intensive Care Unit* Running title: Evaluation of the Vancomycin DosageRegimen Mitsuru Irikura,1 Ayako Fujiyama,1 Fumi Saita,1 Shiori Fukushima,1 Hiroki Kitaoka,2 Terumi ...
[PDF] from iums.ac.irN Rajput, VK Dumka… - Iranian Journal of Pharmacology …, 2011 - ijpt.iums.ac.ir ABSTRACT The pharmacokinetics of cefpirome after a single intravenous injection of 10 mg.kg-1 was studied in febrile cross-bred calves. E. coli endotoxin was administered intravenously to induce fever in calves. Blood samples were collected at different time intervals and ... Related articles - All 2 versions
M Bouillon-Pichault, R Nabbout, S Chhun, E Rey… - Epilepsy research, 2011 - Elsevier ... Available online 21 January 2011. Summary. Purpose. To determine the range of topiramate (TPM) concentrations obtained in children under 4 with the recommended dosageregimen (3–9 mg/kg/day) and to compare them to adult target ranges. Methods. ... All 4 versions